3-Methyl-1,2-cyclopentanedione down-regulates age-related NF-κB signaling cascade

Journal of Agricultural and Food Chemistry

Volumn 55, Issue 16, 2007, Pages 6787-6792

  Jae, Heun Chung ^a   Seo, Young Choi ^a   Ji, Young Kim ^a   Dae, Hyun Kim ^a   Jae, Won Lee ^a   Jae, Sue Choi ^b   Hae, Young Chung ^a  

^a Pusan National University   (South Korea)

^b Pukyong National University   (South Korea)

Author keywords

3 MCP; Aging; Coffee extracts; Inflammation; NF B

Indexed keywords

3 METHYL 1,2 CYCLOPENTANEDIONE; 3-METHYL-1,2-CYCLOPENTANEDIONE; ANTIINFLAMMATORY AGENT; CYCLOPENTANE DERIVATIVE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; UNCLASSIFIED DRUG;

AGING; ANIMAL; ARTICLE; CHEMISTRY; COFFEE; DOWN REGULATION; DRUG EFFECT; FISCHER 344 RAT; GENETICS; INFLAMMATION; MALE; METABOLISM; RAT; SIGNAL TRANSDUCTION;

AGING; ANIMALS; ANTI-INFLAMMATORY AGENTS; COFFEE; CYCLOPENTANES; DOWN-REGULATION; INFLAMMATION; MALE; NF-KAPPA B; RATS; RATS, INBRED F344; SIGNAL TRANSDUCTION;

ANIMALIA; RATTUS;

EID: 34548051068     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf070952p     Document Type: Article

References (32)

1. Tracy, R. P. Emerging relationships of inflammation, cardiovascular disease, and chronic diseases of aging. Int. J. Obes. Relat. Metab. Disord. 2003, 3, 29-34.
2. Banning, M. The principles of inflammation in the development of rheumatoid arthritis. Br. J. Nurs. 2005, 14, 277-283.
3. Caruso, C.; Lio, D.; Cavallone, L.; Franceschi, C. Aging, longevity, inflammation, and cancer. Ann. N. Y. Acad. Sci. 2004, 1028, 1-13.
4. Baldwin, A. S. Series introduction: The transcription factor NF-κB and human disease J. Clin. Invest. 2001, 107 (1), 3-6.
5. Zandi, E.; Rothwarf, D. M.; Delhase, M.; Hayakawa, M.; Karin, M. The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation. Cell 1997, 91, 243-252.
6. Karin, M. The beginning of the end: IκB kinase (IKK) and NF-κB activation. J. Biol. Chem. 1999, 274, 27339-27342.
7. Chen, C.; Rosenbloom, C. L.; Anderson, D. C.; Manning, A. M. Selective inhibition of E-selectin, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 expression by inhibitors of IκBα phosphorylation. J. Immunol. 1995, 155, 3538-3545.
8. Tak, P. P.; Firestein, G. S. NF-κB: A key role in inflammatory diseases. J. Clin. Invest. 2001, 107, 7-11.
9. Atanasov, A.; Dzyakanchuk, A.; Schweizer, R.; Nashev, L.; Maurer, E.; Odermatt, A. Coffee inhibits the reactivation of glucocorticoids by 11-β-hydroxysteroid dehydrogenase type 1: A glucocorticoid connection in the anti-diabetic action of coffee. FEBS Lett. 2006, 580, 4081-4085.
10. Kozuma, K.; Tsuchiya, S.; Kohori, J.; Hase, T.; Tokimitsu, I. Anti-hypertensive effect of green coffee bean extracts on mildly hypertensive subjects. Hypertens. Res. 2005, 28, 711-718.
11. Kim, A. R.; Kim, H. S.; Choi, J. S.; Chang, G. Y.; Kim, Y. J.; Chung, H. Y. Selective peroxynitrite scavenging activity of 3-methyl-1,2-cyclopentanedione from coffee extract. J. Pharm. Pharmacol. 2002, 54, 1385-1392.
12. Corsini, E.; Terzoli, A.; Bruccoleri, A.; Marinovich, M.; Galli, C. L. Induction of tumor necrosis factor a in vivo by a skin irritant, tributyltin, through activation of transcription factors: Its pharmacological modulation by anti-inflammatory drugs. J. Invest. Dermatol. 1997, 108, 892-896.
13. Lebel, C. P.; Ischiropoulos, H.; Bondy, S. C. Evaluation of the probe 2′,7′-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem. Res. Toxicol. 1992, 5, 227-231.
14. Koya, D.; Hayashi, K.; Kitada, M.; Kashiwagi, A.; Kikkawa, R.; Haneda, M. Effects of anti-oxidants in diabetes-induced oxidative stress in the glomeruli of diabetic rats. J. Am. Soc. Nephrol. 2003, 14, 250-253.
15. Poljokovic, M.; Nygren, J. M.; Persson, K. Signaling pathways regulating inducible nitric oxide synthase expression in human kidney epithelial cells. Eur. J. Pharmacol. 2003, 469, 21-28.
16. Karin, M. How NF-κB is activated: The role of the IκB kinase (IKK) complex. Oncogene 1999, 18 (49), 115-124.
17. Tedgui, A.; Mallat, Z. Anti-inflammatory mechanisms in the vascular wall. Circ. Res. 2001, 88, 877-887.
18. Helenius, M.; Hanninen, M.; Lehtinen, S. K.; Salminen, A. Aging-induced up-regulation of nuclear binding activities of oxidative stress responsive NF-κB transcription factor in mouse cardiac muscle. J. Mol. Cell Cardiol. 1996, 28, 487-498.
19. Go, E. K.; Jung, K. J.; Kim, J. Y.; Yu, B. P.; Chung, H. Y. Betaine suppresses proinflammatory signaling during aging: The involvement of nuclear factor-κB via nuclear factor-inducing kinase/IκB kinase and mitogen-activated protein kinases. J. Gerontol., A: Biol. Sci. Med. Sci. 2005, 60 (10), 1252-1264.
20. Haddad, J. J. Oxygen sensing and oxidant/redox-related pathways. Biochem. Biophys. Res. Commun. 2004, 316, 969-977.
21. Chung, H. Y.; Kim, H. J.; Kim, J. W.; Yu, B. P. The inflammation hypothesis of aging: Molecular modulation by calorie restriction. Ann. N.Y. Acad. Sci. 2000, 928, 327-335.
22. Mukai, Y.; Shimokawa, H.; Higashi, M.; Morikawa, K.; Matoba, T.; Hiroki, J.; Kunihiro, I.; Talukder, H. M.; Takeshita, A. Inhibition of renin-angiotensin system ameliorates endothelial dysfunction associated with aging in rats. Arterioscler., Thromb., Vasc. Biol. 2002, 22, 1445-1450.
23. Heymes, C.; Habib, A.; Yang, D.; Mathieu, E.; Marotte, F.; Samuel, J.; Boulanger, C. M. Cyclo-oxygenase-1 and -2 contribution to endothelial dysfunction in aging. Br. J. Pharmacol. 2000, 131, 804-810.
24. Garfinkel, S.; Brown, S.; Wessendorf, J. H.; Maciag, T. Post-transcriptional regulation of interleukin 1α in various strains of young and senescent human umbilical vein endothelial cells. Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 1559-1563.
25. Matz, R. L.; Schott, C.; Stoclet, J. C.; Andriantsitohaina, R. Age-related endothelial dysfunction with respect to nitric oxide, endothelium-derived hyperpolarizing factor, and cyclooxygenase products. Physiol. Res. 2000, 49, 11-18.
26. Chung, H. Y.; Sung, B. K.; Jung, K. J.; Zou, Y.; Yu, B. P. The molecular inflammatory process in aging. Antioxid. Redox. Signaling 2006, 8, 572-581.
27. Lee, H. C.; Wei, Y. H. Mitochondrial role in life and death of the cell. J. Biomed. Sci. 2000, 7, 2-15.
28. Yu, B. P. Aging and oxidative stress: Modulation by dietary restriction. Free Radical Biol. Med. 1996, 21, 651-668.
29. Kim, H. J.; Jung, K. J.; Yu, B. P.; Cho, C. G.; Choi, J. S.; Chung, H. Y. Modulation of redox-sensitive transcription factors by calorie restriction during aging. Mech. Aging Dev. 2002, 123, 1589-1595.
30. Marx, N.; Kehrle, B.; Kohlhammer, K.; Grub, M.; Koeing, W.; Hombach, V.; Libby, P.; Plutzky, J. PPAR activators as anti-inflammatory mediators in human T lymphocytes: Implications for atherosclerosis and transplantation-associated arteriosclerosis. Circ. Res. 2002, 90, 703-710.
31. Planavila, A.; Laguna, J. C.; Vazquez-Carrera, M. Atorvastatin improves peroxisome proliferator-activated receptor signaling in cardiac hypertrophy by preventing nuclear factor-κB activation. Biochim. Biophys. Acta 2005, 1687, 76-83.
32. Rival, Y.; Beneteau, N.; Taillandier, T.; Pezet, M.; Dupont-Passelaigue, E.; Patoiseau, J. F.; Junquero, D.; Colpaert, F. C.; Delhon, A. PPAR α and PPAR δ activators inhibit cytokine-induced nuclear translocation of NF-κB and expression of VCAM-1 in EAhy926 endothelial cells. Eur. J. Pharmacol. 2002, 435, 143-151.